Regeneron's bid to acquire the bankrupt genetic testing firm 23andMe for $256 million has likely come to an end.

Anne Wojcicki’s nonprofit, TTAM Research Institute, has received court approval to acquire 23andMe, the genetic testing ...

Regeneron Pharmaceuticals (REGN) exits buyout race for 23andMe as Anne Wojcicki's TTAM Research offers a superior $305M bid. Read more here.

CT is your last chance to file a claim with 23andMe for a 2023 data breach that may have compromised your genetic data.

A bankruptcy court gave the green light for TTAM Research Institute - a firm launched by 23andMe's co-founder and former CEO ...

Walsh on Friday, marks the end of a monthslong bidding war between TTAM and Regeneron Pharmaceuticals — a biotech ... Under the deal, TTAM will acquire 23andMe’s signature “Personal Genome Service” ...

Anne Wojcicki’s nonprofit gets court approval to buy 23andMe for $305 million Under the deal, TTAM will acquire 23andMe’s signature “Personal Genome Service” provided through the company ...

The DNA data of millions of people who used 23andMe's services won't be sold to a pharmaceutical company. A bankruptcy judge ...